A US District Court has dismissed a case against Medtronic over the Fidelis lead failures. The decision follows the significant precedent-setting Supreme Court decision last year in Riegel v Medtronic.
You can read the Wall Street Journal story or the Medtronic press release by clicking below.
The ACC, the AHA, and a whole alphabet soup worth of other cardiovascular organizations (SCAI, STS, AATS, ASNC, ASE, HFSA SCCT) have published (or in some cases just endorsed) a report, called the ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization. The report will probably provide comfort to those who were big supporters of COURAGE. I’m guessing this will only initiate a new round of debate. It seems unlikely that there will be a widespread breakout of peace over this issue in 2009.
You can read a Dow Jones news story about the report.
Duke researchers have linked variations in the neuropeptide Y (NPY) gene to early cardiovascular disease. The article appears in the Public Library of Science Genetics.
You can read a news story at Science Daily.